Table 1.
Research Cohorts Statistics
| TARGET | GSE21257 | GSE32981 | GSE49003 | GSE39055 | |
|---|---|---|---|---|---|
| Event | |||||
| Alive | 55 | 30 | 18 (Non-recurrence) | ||
| Dead | 30 | 23 | 18 (Recurrence) | ||
| Gender | |||||
| Female | 37 | 19 | 10 | 17 | |
| Male | 48 | 34 | 13 | 19 | |
| DiseaseAtDiagnosis | |||||
| Metastatic | 22 | 34 | 11 | 6 | |
| Non | 63 | 19 | 12 | 6 | |
| Age | |||||
| Median | 14.09 | 16.67 | 18 | 11 | |
| Mean | 14.8 | 18.71 | 21.35 | 13.5 | |
| Overall Survival (mean days)* | * | * | |||
| Alive | 1787.9 | 2755 | 2152 | ||
| Dead | 894.4 | 1145 | 1111.7 |
Notes: GSE49003 refers to four osteosarcoma cell line, of which KHOS and KRIB are metastatic types, and HOS and U2OS are non-metastatic types. *Indicates a significant difference in overall survival time (OS).